Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: GU81, a VEGFR2 antagonist peptoid, enhances the anti-tumor activity of doxorubicin in the murine MMTV-PyMT transgenic model of breast cancer

Figure 3

Combination therapy of GU81 and doxorubicin prevents transition from a premalignant to an invasive phenotype. Tumor tissue was harvested, fixed in formalin, sectioned, and stained with hematoxylin and eosin. Images representative of at least 3 tumors from each group are shown. Note the dramatic reduction in the number of invasive cells induced by combination therapy. Total magnification 200×; scale bar, 50 μm.

Back to article page